The Valley Desk

NCT05026866 · Interventional trial

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Overall registry status Active not recruiting

Phase 3

Conditions Alzheimer Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov